OpenAI reserves stronger health advice for ChatGPT premium subscribers

The detail worth sitting with is that the gap isn't cosmetic. Routing health queries to a materially weaker model for free users means the reliability floor for medical guidance is now explicitly set by willingness to pay, not by platform-wide safety standards. OpenAI is, in effect, treating health accuracy as a premium feature rather than a baseline obligation.

This is largely disconnected from recent activity in our archive, as we have no prior coverage to anchor it to. But it belongs squarely in the broader conversation about how AI companies are transitioning from access-based monetization (free vs. paid) to capability-based monetization (worse vs. better answers for the same question). That shift has different stakes in health contexts than in, say, coding assistance, because the downstream cost of a degraded answer is not a broken script but a missed symptom or a delayed care decision. The Apple Health integration amplifies this by pulling in personal medical records, raising the consequence of any model-quality shortcut.

Watch whether any US state attorney general or the FTC opens an inquiry into whether tiered health advice quality constitutes an unfair or deceptive practice under consumer protection statutes. If a formal investigation is announced within six months, it signals regulators are willing to treat model-tier decisions as a health equity issue, not just a product choice.